Clinical Trial Update: Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

View source ↗

Summary

A completed clinical trial studied genotyping infarct patients to tailor and normalize thienopyridine therapy, potentially improving treatment response in acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Biotronik France | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Status: COMPLETED